COPD Exacerbation Acute
45
6
7
19
Key Insights
Highlights
Success Rate
95% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
2.2%
1 terminated out of 45 trials
95.0%
+8.5% vs benchmark
11%
5 trials in Phase 3/4
16%
3 of 19 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 19 completed trials
Clinical Trials (45)
The Italian Registry of Patients With Chronic Obstructive Pulmonary Disease
The Effect of Airway and Chest Wall Oscillation on Respiratory Functions in COPD Patients in Acute Exacerbation
Assessing Optimal Inhaler Strategies During Acute Exacerbations of COPD (AECOPDs) Using Oscillometry
Evaluation of High Dose Prednisolone Pharmacokinetics in the Acute and Chronic Setting
A Repeat Ascending Dosing Study of the Safety and Clinical Activity of R-3750 in Patients With Mild to Moderate COPD
Study on Home Obstructive Respiratory Exacerbations
RCT of Vapendavir in Patients With COPD and Human Rhinovirus/Enterovirus Upper Respiratory Infection
PSV Versus ASV With Intellisync Mode for Delivery of NIV in AECOPD
Neuromuscular Electrical Stimulation in COPD/Community Acquired Pneumonia
ProAir Digihaler in COPD Disease Management: A Real World Study
Standard vs Targeted Oxygen Therapy Prehospital for Chronic Obstructive Pulmonary Disease
The Reducing REVISITS Study: A Cluster RCT
The Use of Medical Devices to Monitor Chronic Obstructive Pulmonary Disease Patients Study BREATH-TRACHER 2
The Use of Medical Devices to Monitor Chronic Obstructive Pulmonary Disease Patients Study BREATH-TRACHER 1
Study on Acupuncture Treatment of Chronic Airway Diseases(Asthma and Chronic Obstructive Pulmonary Disease)
Identification of Patients Admitted With COPD Exacerbations and Predicting Readmission Risk Using Machine Learning
A Study to Evaluate the Efficacy and Safety of Sitafloxacin in Adult Subjects With Acute Exacerbation of Chronic Obstructive Pulmonary Disease
Effectiveness of Low-Dose Theophylline for the Management of Biomass-Associated COPD
Predictors of Acute Exacerbation in Patients With COPD - an Observational Study
Is a Collective Person-centered Dialogue Intervention for Hospitalised COPD Patients Feasible?